Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia

Authors: Osonoi T, Shirabe S, Saito M, Hosoya M, Watahiki N, Douguchi S, Ofuchi K, Katoh M

Source: Diabetes, Metabolic Syndrome and Obesity, Vol Volume 16, Pp 1799-1808 (2023)

Subject Terms: dapagliflozin, anemia, hemoglobin, iron metabolism, body composition, Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: https://www.dovepress.com/dapagliflozin-improves-erythropoiesis-and-iron-metabolism-in-type-2-di-peer-reviewed-fulltext-article-DMSO; https://doaj.org/toc/1178-7007

Access URL: https://doaj.org/article/403cc7800e69444bb04fb38ad772efa4

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

Authors: Fukushima, Y, Hamamoto, Y, Hisatomi, A, Ide, Y, Inoue, S, Kawada, T, Kim, H, Kiyosue, A, Matoba, K, Matsuoka, O, Nishimura, H, Noguchi, M, Osonoi, T, Sawada, S, Shibasaki, Y, Shin, K, Yamada, Y, Yamada, Yuichiro ^*, Katagiri, Hideki, Hamamoto, Yoshiyuki, Deenadayalan, Srikanth, Navarria, Andrea, Nishijima, Keiji, Seino, Yutaka

Source: In The Lancet Diabetes & Endocrinology May 2020 8(5):377-391

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Authors: Arisaka, T, Asakura, T, Azuma, N, Fukuda, S, Fukushima, Y, Harada, N, Inoue, S, Ishida, H, Ishii, H, Ishikawa, S, Jinnouchi, H, Kaneko, S, Kanno, K, Kato, M, Kato, Y, Kawada, T, Kim, H, Kiyosue, A, Matsuoka, O, Miho, O, Nakamoto, S, Nakamura, S, Nakanishi, S, Nishimura, H, Numata, A, Ohama, T, Okabe, T, Okuguchi, F, Osonoi, T, Sasaki, T, Seino, H, Shin, K, Shiraiwa, T, Sugiura, T, Wada, S, Yamauchi, A, Yabe, Daisuke ^*, Nakamura, Jiro, Kaneto, Hideaki, Deenadayalan, Srikanth, Navarria, Andrea, Gislum, Mette, Inagaki, Nobuya

Source: In The Lancet Diabetes & Endocrinology May 2020 8(5):392-406

Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study

Authors: Osonoi T, Saito M, Koda N, Douguchi S, Nakano T, Ofuchi K, Katoh M

Source: Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 3497-3506 (2020)

Subject Terms: dpp-4 inhibitor, α-glucosidase inhibitor, metformin, egfr slope, type 2 diabetes, Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: https://www.dovepress.com/add-on-therapy-with-dpp-4-inhibitors-may-improve-renal-function-declin-peer-reviewed-article-DMSO; https://doaj.org/toc/1178-7007

Access URL: https://doaj.org/article/8b5d79d40e3f4f0ba712bb5cf5f548e4

Effect of food on the bioavailability of empagliflozin/linagliptin combination tablet in healthy Japanese male adults —A randomized, single-dose, two-sequence crossover study—

Authors: Osonoi, T.

Source: Yakuri to chiryo. 46(3):343-354

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN615566103&indx=1&recIds=ETOCRN615566103

Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin

Authors: Osonoi, T., Saito, M., Hariya, N., Goto, M., Mochizuki, K.

Source: PEPTIDES -FAYETTEVILLE NEW YORK- ELSEVIER-. 86:118-125

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382243663&indx=1&recIds=ETOCRN382243663

Insulin degludec versus insulin glargine, both once daily as add-on to existing orally administered antidiabetic drugs in insulin-naive Japanese patients with uncontrolled type 2 diabetes: subgroup analysis of a pan-Asian, treat-to-target phase 3 trial

Authors: Osonoi, T., Onishi, Y., Nishida, T., Hyllested-Winge, J., Iwamoto, Y.

Source: DIABETOLOGY INTERNATIONAL. 7(2):141-147

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN377615669&indx=1&recIds=ETOCRN377615669

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial

Authors: Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Onuma, T., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y.

Source: Diabetes care. 39(3):455-464

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN605123039&indx=1&recIds=ETOCRN605123039

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Authors: Mita, T., Katakami, N., Yoshii, H., Onuma, T., Kaneto, H., Osonoi, T., Shiraiwa, T., Kosugi, K., Umayahara, Y., Yamamoto, T.

Source: Diabetes care. 39(1):139-148

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN604346070&indx=1&recIds=ETOCRN604346070

Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study

Authors: Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.

Source: DIABETES OBESITY AND METABOLISM. 17(8):800-804

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN374998377&indx=1&recIds=ETOCRN374998377

Hydrogen gas production is associated with reduced interleukin-1β mRNA in peripheral blood after a single dose of acarbose in Japanese type 2 diabetic patients

Authors: Tamasawa, A., Mochizuki, K., Hariya, N., Saito, M., Ishida, H., Doguchi, S., Yanagiya, S., Osonoi, T.

Source: EUROPEAN JOURNAL OF PHARMACOLOGY. 762:96-101

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN371433544&indx=1&recIds=ETOCRN371433544

Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes – An 8-year prospective study

Authors: Katakami, N., Kaneto, H., Matsuoka, T. a., Takahara, M., Osonoi, T., Saitou, M., Kawai, K., Ishibashi, F., Kashiwagi, A., Kawamori, R.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 235(2):408-414

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN356063889&indx=1&recIds=ETOCRN356063889

Cotreatment with the a-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in type 2 diabetic Japanese patients

Authors: Imai, C., Saito, M., Mochizuki, K., Fuchigami, M., Goda, T., Osonoi, T.

Source: METABOLISM. 63(6):746-753

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN352988259&indx=1&recIds=ETOCRN352988259

Quantitative Analytical Method for Determining the Levels of Gastric Inhibitory Polypeptides GIP~1~-~4~2 and GIP~3~-~4~2 in Human Plasma Using LC-MS/MS/MS

Authors: Miyachi, A., Murase, T., Yamada, Y., Osonoi, T., Harada, K.-i.

Source: JOURNAL OF PROTEOME RESEARCH. 12(6):2690-2699

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN334558105&indx=1&recIds=ETOCRN334558105

Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes

Authors: Katakami, N., Kaneto, H., Matsuoka, T. a., Takahara, M., Maeda, N., Shimizu, I., Ohno, K., Osonoi, T., Kawai, K., Ishibashi, F.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 220(2):437-442

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN305467867&indx=1&recIds=ETOCRN305467867

Transforming growth factor b1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes

Authors: Katakami, N., Kaneto, H., Osonoi, T., Kawai, K., Ishibashi, F., Imamura, K., Maegawa, H., Kashiwagi, A., Watada, H., Kawamori, R.

Source: DIABETES RESEARCH AND CLINICAL PRACTICE. 94(3):e57-e60

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN303117451&indx=1&recIds=ETOCRN303117451

Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes

Authors: Katakami, N., Kaneto, H., Takahara, M., Matsuoka, T. A., Imamura, K., Ishibashi, F., Kanda, T., Kawai, K., Osonoi, T., Matsuhisa, M.

Source: DIABETES RESEARCH AND CLINICAL PRACTICE. 92(3):e57-e60

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN292130786&indx=1&recIds=ETOCRN292130786

Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients

Authors: Katakami, N., Kaneto, H., Osonoi, T., Saitou, M., Takahara, M., Sakamoto, F., Yamamoto, K., Yasuda, T., Matsuoka, T. a., Matsuhisa, M.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 214(2):442-447

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN285921026&indx=1&recIds=ETOCRN285921026

Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients

Authors: Katakami, N., Kaneto, H., Matsuoka, T. a., Takahara, M., Imamura, K., Ishibashi, F., Kanda, T., Kawai, K., Osonoi, T., Kashiwagi, A.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 212(2):534-538

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN289624800&indx=1&recIds=ETOCRN289624800

The a-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus

Authors: Osonoi, T., Saito, M., Mochizuki, K., Fukaya, N., Muramatsu, T., Inoue, S., Fuchigami, M., Goda, T.

Source: METABOLISM. 59(12):1816-1822

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN281430954&indx=1&recIds=ETOCRN281430954